• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2型糖尿病患者的肾周脂肪厚度与非酒精性脂肪性肝病相关。

The Perirenal Fat Thickness Was Associated with Nonalcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Mellitus.

作者信息

Yang Yuxian, Li Shuting, Xu Yuechao, Ke Jing, Zhao Dong

机构信息

Center for Endocrine Metabolism and Immune Diseases, Beijing Luhe Hospital, Capital Medical University, Beijing, People's Republic of China.

出版信息

Diabetes Metab Syndr Obes. 2022 May 11;15:1505-1515. doi: 10.2147/DMSO.S350579. eCollection 2022.

DOI:10.2147/DMSO.S350579
PMID:35586202
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9109981/
Abstract

PURPOSE

Obesity is an important risk factor for nonalcoholic fatty liver disease (NAFLD). Perirenal fat and paranephric fat were seldom studied in NAFLD. We aimed to explore the relationship between perirenal fat thickness (PrFT) and paranephric fat thickness (PnFT) and NAFLD in patients with type 2 diabetes mellitus (T2DM).

PATIENTS AND METHODS

A total of 493 diabetic patients including 231 NAFLD patients were enrolled in our study from September 2019 to December 2020. Patients with NAFLD were categorized into three subgroups according to the severity and fibrosis risk of NAFLD. Anthropometric indices and clinical characteristics were collected from clinical records. PrFT and PnFT were measured via ultrasound. Multivariate logistic regression analysis was used to assess the association between PrFT, PnFT and presence, severity and advanced fibrosis risk of NAFLD.

RESULTS

Compared with non-NAFLD patients, those with NAFLD had significantly higher PrFT and PnFT. The PrFT and PnFT were independently associated with presence of NAFLD and the PrFT was independently associated with the advanced fibrosis risk of NAFLD after adjusting confounding factors.

CONCLUSION

The PrFT was independently associated with the presence and advanced fibrosis risk of NAFLD in patients with T2DM.

摘要

目的

肥胖是非酒精性脂肪性肝病(NAFLD)的重要危险因素。肾周脂肪和肾旁脂肪在NAFLD中的研究较少。我们旨在探讨2型糖尿病(T2DM)患者肾周脂肪厚度(PrFT)和肾旁脂肪厚度(PnFT)与NAFLD之间的关系。

患者与方法

2019年9月至2020年12月,共有493例糖尿病患者纳入本研究,其中231例为NAFLD患者。根据NAFLD的严重程度和纤维化风险,将NAFLD患者分为三个亚组。从临床记录中收集人体测量指标和临床特征。通过超声测量PrFT和PnFT。采用多因素logistic回归分析评估PrFT、PnFT与NAFLD的存在、严重程度及晚期纤维化风险之间的关联。

结果

与非NAFLD患者相比,NAFLD患者的PrFT和PnFT显著更高。在调整混杂因素后,PrFT和PnFT与NAFLD的存在独立相关,且PrFT与NAFLD的晚期纤维化风险独立相关。

结论

PrFT与T2DM患者NAFLD的存在及晚期纤维化风险独立相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/beb1/9109981/cb175b54a976/DMSO-15-1505-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/beb1/9109981/3261cf1ca32e/DMSO-15-1505-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/beb1/9109981/96b478429494/DMSO-15-1505-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/beb1/9109981/cb175b54a976/DMSO-15-1505-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/beb1/9109981/3261cf1ca32e/DMSO-15-1505-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/beb1/9109981/96b478429494/DMSO-15-1505-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/beb1/9109981/cb175b54a976/DMSO-15-1505-g0003.jpg

相似文献

1
The Perirenal Fat Thickness Was Associated with Nonalcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Mellitus.2型糖尿病患者的肾周脂肪厚度与非酒精性脂肪性肝病相关。
Diabetes Metab Syndr Obes. 2022 May 11;15:1505-1515. doi: 10.2147/DMSO.S350579. eCollection 2022.
2
The perirenal fat thickness was independently associated with serum uric acid level in patients with type 2 diabetes mellitus.肾周脂肪厚度与 2 型糖尿病患者的血清尿酸水平独立相关。
BMC Endocr Disord. 2022 Aug 20;22(1):210. doi: 10.1186/s12902-022-01081-9.
3
Perirenal fat thickness and liver fat fraction are independent predictors of MetS in adults with overweight and obesity suspected with NAFLD: a retrospective study.肾周脂肪厚度和肝脏脂肪分数是疑似非酒精性脂肪性肝病的超重和肥胖成年人代谢综合征的独立预测因素:一项回顾性研究。
Diabetol Metab Syndr. 2023 Mar 23;15(1):56. doi: 10.1186/s13098-023-01033-w.
4
Perirenal Fat Thickness is Associated with Metabolic Dysfunction-Associated Fatty Liver Disease in Type 2 Diabetes Mellitus.肾周脂肪厚度与2型糖尿病患者代谢功能障碍相关脂肪性肝病有关。
Diabetes Metab Syndr Obes. 2023 Jun 28;16:1953-1965. doi: 10.2147/DMSO.S415477. eCollection 2023.
5
Perirenal fat thickness as a superior obesity-related marker of subclinical carotid atherosclerosis in type 2 diabetes mellitus.肾周脂肪厚度是 2 型糖尿病患者亚临床颈动脉粥样硬化的一种较好的肥胖相关标志物。
Front Endocrinol (Lausanne). 2023 Oct 27;14:1276789. doi: 10.3389/fendo.2023.1276789. eCollection 2023.
6
Low serum levels of bone turnover markers are associated with perirenal fat thickness in patients with type 2 diabetes mellitus.2型糖尿病患者血清骨转换标志物水平低与肾周脂肪厚度相关。
Endocr Connect. 2021 Oct 13;10(10):1337-1343. doi: 10.1530/EC-21-0449.
7
Perirenal fat thickness contributes to the estimated 10-year risk of cardiovascular disease and atherosclerotic cardiovascular disease in type 2 diabetes mellitus.肾周脂肪厚度与 2 型糖尿病患者心血管疾病和动脉粥样硬化性心血管疾病的 10 年预估风险有关。
Front Endocrinol (Lausanne). 2024 Jul 8;15:1434333. doi: 10.3389/fendo.2024.1434333. eCollection 2024.
8
The Relationship between Perirenal Fat Thickness and Reduced Glomerular Filtration Rate in Patients with Type 2 Diabetes.2 型糖尿病患者肾周脂肪厚度与肾小球滤过率降低的关系。
J Diabetes Res. 2020 Jun 28;2020:6076145. doi: 10.1155/2020/6076145. eCollection 2020.
9
Para-perirenal fat thickness is associated with reduced glomerular filtration rate regardless of other obesity-related indicators in patients with type 2 diabetes mellitus.无论其他肥胖相关指标如何,2 型糖尿病患者的肾周脂肪厚度与肾小球滤过率降低有关。
PLoS One. 2023 Oct 26;18(10):e0293464. doi: 10.1371/journal.pone.0293464. eCollection 2023.
10
Perirenalfat thickness is associated with bone turnover markers and bone mineral density in postmenopausal women with type 2 diabetes mellitus.绝经后 2 型糖尿病女性的肾周脂肪厚度与骨转换标志物和骨密度相关。
Front Endocrinol (Lausanne). 2022 Oct 25;13:990667. doi: 10.3389/fendo.2022.990667. eCollection 2022.

引用本文的文献

1
Perirenal adipose tissue accumulation mediates the adverse impact of the atherogenic index of plasma on lower extremity peripheral arterial disease.肾周脂肪组织堆积介导了血浆致动脉粥样硬化指数对下肢外周动脉疾病的不利影响。
Sci Rep. 2025 Jul 1;15(1):22352. doi: 10.1038/s41598-025-08122-y.
2
The association of perirenal adipose tissue accumulation with left ventricular hypertrophy and the mediating role of insulin resistance: a cross-sectional study involving 1112 individuals with type 2 diabetes mellitus.肾周脂肪组织堆积与左心室肥厚的关联及胰岛素抵抗的中介作用:一项涉及1112例2型糖尿病患者的横断面研究。
Front Endocrinol (Lausanne). 2025 Jan 9;15:1465577. doi: 10.3389/fendo.2024.1465577. eCollection 2024.
3

本文引用的文献

1
Triglycerides Mediate Body Mass Index and Nonalcoholic Fatty Liver Disease: A Population-Based Study.甘油三酯介导体重指数与非酒精性脂肪性肝病的关系:一项基于人群的研究。
Obes Facts. 2021;14(2):190-196. doi: 10.1159/000514848. Epub 2021 Mar 29.
2
Implications of Abdominal Adipose Tissue Distribution on Nonalcoholic Fatty Liver Disease and Metabolic Syndrome: A Chinese General Population Study.腹部脂肪组织分布对非酒精性脂肪性肝病和代谢综合征的影响:一项中国一般人群研究。
Clin Transl Gastroenterol. 2021 Feb 17;12(2):e00300. doi: 10.14309/ctg.0000000000000300.
3
Predictors for incidence and remission of nonalcoholic fatty liver disease in obese children and adolescents.
The Interplay of Systemic Inflammation and Oxidative Stress in Connecting Perirenal Adipose Tissue to Hyperuricemia in Type 2 Diabetes Mellitus: A Mediation Analysis.
2型糖尿病中系统性炎症与氧化应激在肾周脂肪组织与高尿酸血症关联中的相互作用:一项中介分析
J Inflamm Res. 2024 Dec 19;17:11319-11329. doi: 10.2147/JIR.S488964. eCollection 2024.
4
Perirenal fat thickness is an independent predictor for metabolic syndrome in steatotic liver disease.肾周脂肪厚度是脂肪性肝病代谢综合征的独立预测因子。
Sci Rep. 2024 Nov 4;14(1):26548. doi: 10.1038/s41598-024-77512-5.
5
Assessing the Prognostic Utility of the New Mayo Adhesive Probability Score in East Asian Populations and its Correlation with Metabolic-Associated Fatty Liver Disease.评估新 Mayo 黏附概率评分在东亚人群中的预后效用及其与代谢相关脂肪性肝病的相关性。
Physiol Res. 2024 Jul 17;73(3):393-403. doi: 10.33549/physiolres.935297.
肥胖儿童和青少年非酒精性脂肪性肝病发病及缓解的预测因素
J Formos Med Assoc. 2022 Jan;121(1 Pt 1):36-42. doi: 10.1016/j.jfma.2021.01.004. Epub 2021 Jan 24.
4
The Relationship between Perirenal Fat Thickness and Reduced Glomerular Filtration Rate in Patients with Type 2 Diabetes.2 型糖尿病患者肾周脂肪厚度与肾小球滤过率降低的关系。
J Diabetes Res. 2020 Jun 28;2020:6076145. doi: 10.1155/2020/6076145. eCollection 2020.
5
Peri-renal fat thickness is positively associated with the urine albumin excretion rate in patients with type 2 diabetes.肾周脂肪厚度与 2 型糖尿病患者的尿白蛋白排泄率呈正相关。
Obes Res Clin Pract. 2020 Jul-Aug;14(4):345-349. doi: 10.1016/j.orcp.2020.06.006. Epub 2020 Jul 9.
6
Global prevalence, incidence, and outcomes of non-obese or lean non-alcoholic fatty liver disease: a systematic review and meta-analysis.全球非肥胖或消瘦非酒精性脂肪性肝病的患病率、发病率和结局:系统评价和荟萃分析。
Lancet Gastroenterol Hepatol. 2020 Aug;5(8):739-752. doi: 10.1016/S2468-1253(20)30077-7. Epub 2020 May 12.
7
Visceral-to-Subcutaneous Abdominal Fat Ratio Is Associated with Nonalcoholic Fatty Liver Disease and Liver Fibrosis.内脏-皮下腹部脂肪比率与非酒精性脂肪性肝病和肝纤维化有关。
Endocrinol Metab (Seoul). 2020 Mar;35(1):165-176. doi: 10.3803/EnM.2020.35.1.165.
8
Established and emerging factors affecting the progression of nonalcoholic fatty liver disease.影响非酒精性脂肪性肝病进展的既存和新兴因素。
Metabolism. 2020 Oct;111S:154183. doi: 10.1016/j.metabol.2020.154183. Epub 2020 Feb 14.
9
Potential Therapeutic Application of Estrogen in Gender Disparity of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis.雌激素在非酒精性脂肪性肝病/非酒精性脂肪性肝炎性别差异中的潜在治疗应用。
Cells. 2019 Oct 15;8(10):1259. doi: 10.3390/cells8101259.
10
The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: A systematic review and meta-analysis.全球 2 型糖尿病患者非酒精性脂肪性肝病和非酒精性脂肪性肝炎的流行病学:系统评价和荟萃分析。
J Hepatol. 2019 Oct;71(4):793-801. doi: 10.1016/j.jhep.2019.06.021. Epub 2019 Jul 4.